PL1960428T3 - Przeciwciała przeciwko amyloidowi beta z glikozylacją w regionie zmiennym - Google Patents

Przeciwciała przeciwko amyloidowi beta z glikozylacją w regionie zmiennym

Info

Publication number
PL1960428T3
PL1960428T3 PL06829502T PL06829502T PL1960428T3 PL 1960428 T3 PL1960428 T3 PL 1960428T3 PL 06829502 T PL06829502 T PL 06829502T PL 06829502 T PL06829502 T PL 06829502T PL 1960428 T3 PL1960428 T3 PL 1960428T3
Authority
PL
Poland
Prior art keywords
glycosylation
variable region
antibodies against
amyloid beta
against amyloid
Prior art date
Application number
PL06829502T
Other languages
English (en)
Inventor
Hansruedi Loetscher
Walter Huber
Diana Schuhbauer
Karl Weyer
Manfred Brockhaus
Bernd Bohrmann
Hans Koll
Andreas Schaubmar
Kurt Lang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PL1960428T3 publication Critical patent/PL1960428T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell
PL06829502T 2005-12-12 2006-12-11 Przeciwciała przeciwko amyloidowi beta z glikozylacją w regionie zmiennym PL1960428T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05027090 2005-12-12
EP06829502A EP1960428B1 (en) 2005-12-12 2006-12-11 Antibodies against amyloid beta with glycosylation in the variable region
PCT/EP2006/011914 WO2007068429A1 (en) 2005-12-12 2006-12-11 Antibodies against amyloid beta 4 with glycosylated in the variable region

Publications (1)

Publication Number Publication Date
PL1960428T3 true PL1960428T3 (pl) 2012-02-29

Family

ID=37745986

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06829502T PL1960428T3 (pl) 2005-12-12 2006-12-11 Przeciwciała przeciwko amyloidowi beta z glikozylacją w regionie zmiennym

Country Status (34)

Country Link
US (2) US8906370B2 (pl)
EP (2) EP2377886A1 (pl)
JP (1) JP5145241B2 (pl)
KR (2) KR20080077132A (pl)
CN (2) CN102659943B (pl)
AR (1) AR057233A1 (pl)
AT (1) ATE517923T1 (pl)
AU (1) AU2006326301B2 (pl)
BR (1) BRPI0619605B8 (pl)
CA (1) CA2632828C (pl)
CR (1) CR10000A (pl)
CY (1) CY1114783T1 (pl)
DK (1) DK1960428T3 (pl)
DO (1) DOP2006000278A (pl)
EC (1) ECSP088524A (pl)
ES (1) ES2368591T3 (pl)
HK (2) HK1130066A1 (pl)
IL (1) IL191004A (pl)
JO (1) JO2824B1 (pl)
MA (1) MA30038B1 (pl)
MY (1) MY155286A (pl)
NO (1) NO346105B1 (pl)
NZ (1) NZ568241A (pl)
PE (3) PE20100684A1 (pl)
PL (1) PL1960428T3 (pl)
PT (1) PT1960428E (pl)
RS (1) RS52004B (pl)
RU (1) RU2438706C2 (pl)
SI (1) SI1960428T1 (pl)
TW (1) TWI382990B (pl)
UA (1) UA99097C2 (pl)
UY (1) UY30003A1 (pl)
WO (1) WO2007068429A1 (pl)
ZA (1) ZA200805038B (pl)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038568A1 (es) * 2002-02-20 2005-01-19 Hoffmann La Roche Anticuerpos anti-a beta y su uso
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
BRPI0619249A2 (pt) 2005-11-30 2011-09-20 Abbott Lab anticorpos anti-globulÈmeros-aß, frações que se ligam a antìgeno destes, hibridomas correspondentes, ácidos nucléicos, vetores, células hospedeiras, métodos de produzir os ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos de usar os ditos anticorpos
CN101506236B (zh) 2005-11-30 2012-12-12 雅培制药有限公司 抗淀粉样β蛋白的单克隆抗体及其用途
PE20100684A1 (es) * 2005-12-12 2010-10-04 Hoffmann La Roche Anticuerpo anti b-4-amiloide que contiene asparagina glicosilada en la region variable de vh
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
CA2671968A1 (en) * 2006-12-11 2008-06-19 F. Hoffmann-La Roche Ag Abeta antibody parenteral formulation
EP2486928A1 (en) 2007-02-27 2012-08-15 Abbott GmbH & Co. KG Method for the treatment of amyloidoses
US8613923B2 (en) 2007-06-12 2013-12-24 Ac Immune S.A. Monoclonal antibody
US8048420B2 (en) 2007-06-12 2011-11-01 Ac Immune S.A. Monoclonal antibody
EP3351557A1 (en) 2007-06-29 2018-07-25 F. Hoffmann-La Roche AG Heavy chain mutant leading to improved immunoglobulin production
EP2527367A1 (en) 2007-08-20 2012-11-28 Glaxo Group Limited Production method
CN101883790B (zh) 2007-10-05 2015-09-09 基因技术公司 抗淀粉样蛋白β抗体在眼病中的用途
MX2010006395A (es) * 2007-12-21 2010-07-01 Hoffmann La Roche Formulacion de anticuerpos.
EP2282773B1 (en) * 2008-05-02 2014-01-15 Seattle Genetics, Inc. Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
US20120282654A1 (en) * 2009-04-29 2012-11-08 Schering Corporation Antibody purification
US20130116413A1 (en) * 2009-12-29 2013-05-09 Dr. Reddy's Laboratories, Inc. Purification of proteins
PE20130527A1 (es) 2010-03-03 2013-05-09 Boehringer Ingelheim Int Polipeptidos de union a a-beta biparatopicos
MX360403B (es) 2010-04-15 2018-10-31 Abbvie Inc Proteinas de union a amiloide beta.
RU2607368C2 (ru) 2010-07-30 2017-01-10 Ац Иммуне С.А. Безопасные и функциональные гуманизированные антитела
JP6147665B2 (ja) 2010-08-14 2017-06-14 アッヴィ・インコーポレイテッド アミロイドベータ結合タンパク質
WO2012142301A2 (en) 2011-04-12 2012-10-18 Quanterix Corporation Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury
EA037797B1 (ru) * 2011-10-25 2021-05-21 Протена Байосайенсиз Лимитед Состав антитела, пригодный для профилактики и лечения амилоидоза, его варианты и способ его получения
EP2786143A4 (en) * 2011-12-02 2015-07-01 Plaxgen Inc PLATE DISTRIBUTION METHOD AND PLATE FORMING AND DETECTION COMPOSITIONS
RU2014140137A (ru) * 2012-03-08 2016-04-27 Ф.Хоффманн-Ля Рош Аг Лекарственный препарат антитела к бета-амилоиду
RS58928B1 (sr) * 2012-08-29 2019-08-30 Hoffmann La Roche Transporter za krvno-moždanu barijeru
CN102998454A (zh) * 2012-12-11 2013-03-27 华中师范大学 一种检测生物体内邻苯二甲酸二丁酯相对含量的方法
US9587022B2 (en) 2012-12-18 2017-03-07 The Rockefeller University Glycan-modified anti-CD4 antibody with improved HIV-1 neutralizing activity
WO2014100139A1 (en) 2012-12-18 2014-06-26 The Rockefeller University Glycan-modified anti-cd4 antibodies for hiv prevention and therapy
MX2015010427A (es) 2013-02-13 2016-03-17 Lab Francais Du Fractionnement Anticuerpos anti-tnf-alfa altamente galactosilados y sus usos.
JP6169885B2 (ja) 2013-05-07 2017-07-26 株式会社日立製作所 精製装置及び精製方法
RU2016107435A (ru) 2013-09-13 2017-10-18 Дженентек, Инк. Композиции и способы обнаружения и количественного определения белка клеток-хозяев в клеточных линиях и рекомбинантные полипептидные продукты
WO2015038888A1 (en) 2013-09-13 2015-03-19 Genentech, Inc. Methods and compositions comprising purified recombinant polypeptides
CN105899192B (zh) 2013-11-22 2019-08-13 国立大学法人东京大学 药物递送用载体、偶联物及含有这些成分的组合物以及它们的施予方法
EP3129051A1 (en) 2014-04-08 2017-02-15 Prothena Biosciences Limited Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein
WO2015165961A1 (en) 2014-04-29 2015-11-05 Affiris Ag Treatment and prevention of alzheimer's disease (ad)
HRP20220304T1 (hr) 2015-06-24 2022-05-13 F. Hoffmann - La Roche Ag Anti-transferinska receptorska protutijela s prilagođenim afinitetom
JP6968055B2 (ja) * 2015-08-21 2021-11-17 ジェネンテック， インコーポレイテッド アフィニティークロマトグラフィーにおける宿主細胞タンパク質の低減方法
AR106189A1 (es) 2015-10-02 2017-12-20 Hoffmann La Roche ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
PE20181004A1 (es) 2015-10-02 2018-06-26 Hoffmann La Roche Anticuerpos biespecificos contra el cd20 humano y el receptor de transferrina humano y metodos de uso
EP3155958B1 (en) * 2015-10-16 2021-11-17 Roche Diabetes Care GmbH A method for operating a system and a system
EP3374379A4 (en) 2015-11-09 2019-05-15 The University Of British Columbia N-TERMINAL EPITOPES IN BETA-AMYLOID AND CONFORMATIONALLY SELECTIVE ANTIBODIES THEREOF
WO2017079835A1 (en) 2015-11-09 2017-05-18 The University Of British Columbia Amyloid beta epitopes and antibodies thereto
US10774120B2 (en) 2015-11-09 2020-09-15 The University Of British Columbia Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
US10792477B2 (en) * 2016-02-08 2020-10-06 Orbusneich Medical Pte. Ltd. Drug eluting balloon
EP3427183A1 (en) * 2016-03-10 2019-01-16 Genomic Vision Method of curvilinear signal detection and analysis and associated platform
WO2017189959A1 (en) 2016-04-29 2017-11-02 Voyager Therapeutics, Inc. Compositions for the treatment of disease
TWI735600B (zh) 2016-07-01 2021-08-11 美商美國禮來大藥廠 抗－N3pGlu類澱粉β肽抗體及其用途
US20180125920A1 (en) 2016-11-09 2018-05-10 The University Of British Columbia Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
JPWO2018221244A1 (ja) * 2017-05-30 2019-11-21 森永乳業株式会社 脳機能改善用組成物
CA3070085A1 (en) 2017-07-18 2019-01-24 Promis Neurosciences Inc. Antibodies to amyloid beta
CN108048477A (zh) * 2017-12-15 2018-05-18 南京理工大学 基于大肠杆菌表达***的制备多肽的方法
EP3778875A1 (en) 2019-08-14 2021-02-17 MaxiVax SA Immortalized myoblast cell lines and uses thereof
JP2023535024A (ja) 2020-07-23 2023-08-15 オター プロシーナ リミテッド 抗ａベータ抗体
PE20231556A1 (es) 2020-11-16 2023-10-03 Hoffmann La Roche Glucoformas de fab ricas en manosa
TW202300517A (zh) 2021-03-12 2023-01-01 美商美國禮來大藥廠 抗類澱粉β抗體及其用途
WO2022251048A1 (en) 2021-05-24 2022-12-01 Eli Lilly And Company Anti-amyloid beta antibodies and uses thereof
CN114591429B (zh) * 2022-05-07 2022-08-09 北京第一生物化学药业有限公司 结合β-淀粉样蛋白的抗体及其用途

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666829A (en) 1985-05-15 1987-05-19 University Of California Polypeptide marker for Alzheimer's disease and its use for diagnosis
GB8601597D0 (en) 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
US5811310A (en) 1986-09-30 1998-09-22 Albert Einstein College Of Medicine Of Yeshiva Univ. The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
CA1339014C (en) 1987-10-08 1997-03-25 Ronald E. Majocha Antibodies to a4 amyloid peptide
JP2780507B2 (ja) * 1991-03-29 1998-07-30 松下電器産業株式会社 内燃機関用フィルタ再生装置
DE69432629T3 (de) 1993-01-25 2008-01-17 Takeda Pharmaceutical Co. Ltd. Antikörper gegen beta-amyloid oder derivative davon und seine verwendung
US5955317A (en) * 1993-01-25 1999-09-21 Takeda Chemical Industries, Ltd. Antibodies to β-amyloids or their derivatives and use thereof
US5443953A (en) * 1993-12-08 1995-08-22 Immunomedics, Inc. Preparation and use of immunoconjugates
GB9416007D0 (en) * 1994-08-08 1994-09-28 Erba Carlo Spa Anthracyclinone derivatives
US5688651A (en) * 1994-12-16 1997-11-18 Ramot University Authority For Applied Research And Development Ltd. Prevention of protein aggregation
WO1996039628A1 (en) * 1995-06-06 1996-12-12 Stemcell Therapeutics L.L.C. GLYCOPROTEIN gp105 ON BL3 HEMATOPOIETIC STEM CELLS
WO1997008320A1 (en) 1995-08-18 1997-03-06 Morphosys Gesellschaft Für Proteinoptimierung Mbh Protein/(poly)peptide libraries
TWI239847B (en) 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
ES2290023T3 (es) * 1999-03-04 2008-02-16 Praecis Pharmaceuticals Incorporated Moduladores de la agregacion del peptido beta-amiloide que comprenden d-aminoacidos.
WO2000077178A1 (en) 1999-06-16 2000-12-21 Boston Biomedical Research Institute IMMUNOLOGICAL CONTROL OF β-AMYLOID LEVELS IN VIVO
WO2001015655A2 (en) 1999-08-31 2001-03-08 Ramot University Authority For Applied Research & Industrial Development Ltd. Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders
US20020094335A1 (en) 1999-11-29 2002-07-18 Robert Chalifour Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
KR20080059676A (ko) 1999-11-29 2008-06-30 뉴로겜 인터내셔널 리미티드 알츠하이머 및 아밀로이드 관련 질병의 예방 및 치료용백신
EP1125905A1 (en) 2000-02-16 2001-08-22 Pepscan Systems B.V. Segment synthesis
CN101670105B (zh) 2000-02-24 2014-08-06 华盛顿大学 螯合淀粉样蛋白β肽的人源化抗体
CA2313828A1 (en) 2000-08-01 2002-02-01 Institut De Recherches Cliniques De Montreal/Ircm Post-translational processing of .beta.-secretase (bace): the pro-and transmembrane/cytosolic domains affect its cellular activity and amyloid a.beta. production
PE20020574A1 (es) 2000-12-06 2002-07-02 Wyeth Corp Anticuerpos humanizados que reconocen el peptido amiloideo beta
ATE385811T1 (de) 2000-12-19 2008-03-15 Palatin Technologies Inc Identifizierung zielgerichteter faltungsstellen in peptiden und proteinen
AU2002257162A1 (en) 2001-04-30 2002-11-11 Eli Lilly And Company Humanized antibodies
DE60230736D1 (de) 2001-04-30 2009-02-26 Lilly Co Eli HUMANISIERTE ANTIKÖRPER DIE DAS BETA-AMYLOID PEPTID ERKENNEN& x9;
DK1944040T3 (da) * 2001-08-17 2012-10-29 Univ Washington Analysefremgangsmåde for Alzheimers sygdom
WO2003016466A2 (en) 2001-08-17 2003-02-27 Eli Lilly And Company ANTI-Aβ ANTIBODIES
AR038568A1 (es) 2002-02-20 2005-01-19 Hoffmann La Roche Anticuerpos anti-a beta y su uso
MY139983A (en) * 2002-03-12 2009-11-30 Janssen Alzheimer Immunotherap Humanized antibodies that recognize beta amyloid peptide
US20040146512A1 (en) 2002-10-09 2004-07-29 Arnon Rosenthal Methods of treating Alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof
DE10303974A1 (de) * 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
PE20100684A1 (es) * 2005-12-12 2010-10-04 Hoffmann La Roche Anticuerpo anti b-4-amiloide que contiene asparagina glicosilada en la region variable de vh
CA2671968A1 (en) * 2006-12-11 2008-06-19 F. Hoffmann-La Roche Ag Abeta antibody parenteral formulation

Also Published As

Publication number Publication date
CY1114783T1 (el) 2016-12-14
AU2006326301B2 (en) 2011-04-21
NO346105B1 (no) 2022-02-21
CN102659943A (zh) 2012-09-12
RS52004B (en) 2012-04-30
US8906370B2 (en) 2014-12-09
CR10000A (es) 2008-07-29
AR057233A1 (es) 2007-11-21
CN101351476B (zh) 2013-04-03
MA30038B1 (fr) 2008-12-01
DOP2006000278A (es) 2007-07-15
RU2438706C2 (ru) 2012-01-10
KR20120089483A (ko) 2012-08-10
CN102659943B (zh) 2015-07-01
EP1960428B1 (en) 2011-07-27
HK1176075A1 (en) 2013-07-19
UY30003A1 (es) 2007-08-31
WO2007068429A1 (en) 2007-06-21
NO20082874L (no) 2008-08-28
BRPI0619605B1 (pt) 2019-08-13
US20090252724A1 (en) 2009-10-08
BRPI0619605A2 (pt) 2011-10-11
KR20080077132A (ko) 2008-08-21
CN101351476A (zh) 2009-01-21
PE20100748A1 (es) 2010-11-12
ES2368591T3 (es) 2011-11-18
EP1960428A1 (en) 2008-08-27
EP2377886A1 (en) 2011-10-19
JP2009520691A (ja) 2009-05-28
US9272031B2 (en) 2016-03-01
JO2824B1 (en) 2014-09-15
RU2008128138A (ru) 2010-01-20
KR101401159B1 (ko) 2014-05-29
DK1960428T3 (da) 2011-08-22
PE20071002A1 (es) 2007-11-19
PE20100684A1 (es) 2010-10-04
PT1960428E (pt) 2011-10-07
BRPI0619605A8 (pt) 2019-01-15
CA2632828A1 (en) 2007-06-21
ATE517923T1 (de) 2011-08-15
ZA200805038B (en) 2009-06-24
HK1130066A1 (en) 2009-12-18
CA2632828C (en) 2012-07-10
TW200736273A (en) 2007-10-01
US20150165022A1 (en) 2015-06-18
UA99097C2 (ru) 2012-07-25
SI1960428T1 (sl) 2011-10-28
ECSP088524A (es) 2008-07-30
AU2006326301A1 (en) 2007-06-21
BRPI0619605B8 (pt) 2021-05-25
IL191004A (en) 2013-08-29
MY155286A (en) 2015-09-30
TWI382990B (zh) 2013-01-21
JP5145241B2 (ja) 2013-02-13
NZ568241A (en) 2011-08-26

Similar Documents

Publication Publication Date Title
PT1960428E (pt) Anticorpos glicosilados na região variável contra beta-amilóide 4
IL289365A (en) Monoclonal antibodies against amyloid beta protein and uses thereof
EP1851245A4 (en) ANTIBODIES DIRECTED AGAINST INTERLEUKIN-1 BETA
IL237167A0 (en) Monoclonal antibodies selective for expressing amyloid, preparations, mixtures and their use
IL205127A (en) Antibody to aβ is humanized, a preparation containing it and its uses
PL2468770T3 (pl) Humanizowane przeciwciało przeciw amyloidowi beta
PL2121754T3 (pl) Pegylowany FAB amyloidu beta
IL187316A0 (en) Anti-interleukin 2 antibodies
PL2379601T3 (pl) Przeciwciało antyidiotypowe przeciw przeciwciału przeciw peptydowi amyloidu beta
IL186500A0 (en) Protein glycosylation
LT2468770T (lt) Humanizuotas antikūnas prieš beta amiloidą
SI1976877T1 (sl) Monoklonska protitelesa proti amiloidnemu beta proteinu in njihove uporabe
GB0525361D0 (en) The anti fod device
HU0500559D0 (en) Hushroom with egg
SI1976877T2 (sl) Monoklonska protitelesa proti amiloidnemu beta proteinu in njihove uporabe
GB0517560D0 (en) Sandwich transporter
PL376079A1 (pl) Piec akumulacyjny obiektu
GB0516424D0 (en) Improvement in the lamp